You just read:

Bioniz Therapeutics Reports Top-Line Phase 1 Clinical Study Results for BNZ-1, A Novel Multi-Cytokine Inhibitor

News provided by

Bioniz Therapeutics, Inc.

Jul 19, 2017, 08:00 ET